The FDA Is Expected to Approve New Narcolepsy Drug
  (7/5/22)
Avadel Pharmaceuticals Plc., the biopharma company behind this treatment, is currently undervalued and rated Outperform, noted an Oppenheimer report. More >

The Return of the Northern Peso
Source: Michael J. Ballanger  (7/5/22)
Expert Michael Ballanger reviews recent movements in the mining and precious metals market and what moves he plans on making as we wait and see whether the Fed will pivot. More >

What Is the Risk of More Downturn?
Source: Adrian Day  (7/5/22)
Expert Adrian Day looks at the state of the market after this year’s 23% decline and discusses the risk of more possible downturn. Find out which companies he thinks are a buy — and which ones need to fly off your radar. More >

Laser Device Co. Gains FDA Approval for Next-Gen Catheter
Source: Streetwise Reports  (7/5/22)
Ra Medical Systems Inc. shares traded 36% higher after the firm reported it received U.S. FDA 510(k) clearance for its DABRA 2.0 Catheter. The DABRA 2.0 is incorporated into the company's DABRA Excimer Laser System which is used by vascular surgeons in procedures to treat lower extremity and peripheral vascular disease. More >

BC Junior Starts Mining Placer Gold
Source: Streetwise Reports  (7/4/22)
You've seen placer gold being mined on Gold Rush, Discovery's gold mining TV show. But one junior explorer just announced that it's started to commercially mine placer gold in south-central British Columbia from a pay channel underneath Lightning Creek. At least one analyst thinks that makes this junior a Speculative Buy. More >

Clive Maund: Enterprise Might Just Pick Up Your Portfolio
Source: Clive Maund  (7/3/22)
In the environment we are now in, the best thing investors can do is find stocks that are impervious to declines in the market indices. Even though they can be hard to find, there are some around, like the one in this story. More >

Company Reports 'Excellent Metallurgical Results' at Quebec Gold Project
  (7/1/22)
The test results bode well for the prefeasibility study of the Canadian explorer's past-producing project in Quebec's historical Val d'Or mining district, noted a Stifel report, and named it the cheapest company in its coverage universe. A Laurentian Bank Securities report called the company's most recent drill results "encouraging." More >

Trial of New Alzheimer's Drug Slated for Early 2023
  (7/1/22)
The biotech behind this product candidate differentiates itself from competitors with its approach to developing selective antibody therapies, noted an Argus Research Co. report. More >

MedTech Co.'s Shares Maneuver Higher on Q1 Revenue Growth
Source: Streetwise Reports  (7/1/22)
Shares of personalized, member-focused healthcare solutions company Accolade Inc. traded 29% higher after the company reported financial results for Q1/23 highlighting a 44% YoY increase in revenue and significant improvements in adjusted gross margin. More >

Quebec Junior All-In for Gold in James Bay
Source: Streetwise Reports  (6/30/22)
Junior explorer Quebec Precious Metals Corp. is focusing on gold in its project in the James Bay territory of Quebec and selling off its non-core properties. It hopes to complete a mineral resource estimate by the end of the third quarter. More >

Chen's Top Picks for Q3
Source: Streetwise Reports  (6/30/22)
Need to know where to go in these turbulent times? Asset manager Chen Lin has some ideas with his top picks for the third quarter. More >

Mining Co. Starts Field Work in Chile, Offers 'High Investment Leverage Potential'
  (6/30/22)
With four priority targets identified, Canadian explorer Golden Arrow Resources Corp. is conducting its initial exploration program at its newly acquired copper-gold-cobalt property, noted a Goldletter International bulletin, and also explains why it believes the company is undervalued. More >

BioNTech and Pfizer Secure $3.2B Vaccine Order from US Govt.
Source: Streetwise Reports  (6/30/22)
Shares of BioNTech SE traded 5% higher after the company together with its partner Pfizer Inc. reported that the two firms have agreed to provide 105 million 30 µg, 10 µg and 3 µg new doses of the SARS-Co-V2 vaccine to the U.S. government in a contract valued at $3.2 billion. The agreement includes a provision allowing the U.S. government to purchase up to an additional 195 million doses, which if exercised would increase the grand total to 300 million doses. More >

Investors May 'Swarm' to This Drone Company With a Golden Opportunity
Source: Tim Weintraut  (6/30/22)
Red Cat Holdings, a hardware and software provider to the drone industry, continues to innovate, and this industry observer calls it a "strong player to keep an eye on." More >

Dakota Gold Joins Russell 3000, GDXJ in Same Week
Source: Streetwise Reports  (6/29/22)
The Russell 3000 is home to the top 3,000 U.S.-traded equities. One junior gold explorer with a significant land package in the Black Hills of South Dakota — where the Homestake gold mine once produced more than 40 million oz gold — has joined the Russell 3000 and the VanEck Junior Gold Miners ETF, better known as the GDXJ. Heady days for a company that started trading on the NYSE American exchange in April. More >

New Alzheimer's Drug Shows Promise as Monotherapy
  (6/29/22)
Athira Pharma Inc.'s treatment with this small molecule alone resulted in improvements related to both primary and secondary endpoints, indicating pharmacological activity, noted a BTIG report. More >

Mining Co. Creates Value for Investors Via Several Assets
  (6/29/22)
MAG Silver Corp. offers a robust exploration pipeline, in addition to its project in Mexico that is close to reaching commercial production, noted a PI Financial report. More >

Spanish Deposit Offers 'The Best Bang for the Buck'
  (6/29/22)
Results of Emerita Resources Corp.'s first drill hole there suggest the prospective potential of this high-grade project, noted a Clarus Securities report. More >

Dental & Animal Health Supplier Posts 10% Yearly Sales Gains
Source: Streetwise Reports  (6/29/22)
Shares of Patterson Companies Inc. traded 11% higher after the dental supply and animal health products distributor reported Q4/22 and FY/22 financial results highlighting a 9.9% increase in annual sales and an expansion in operating margins. More >

Small Cap Joins With Japan Pharma to Advance Next Generation Cancer Treatment
Source: Streetwise Reports  (6/28/22)
Shares of Sutro Biopharma Inc. traded 21% higher after the company announced it entered into a global collaboration agreement with Japan's Astellas Pharma to advance three novel immunostimulatory antibody-drug conjugates. More >

Drug Co. to Conduct P1/2a Trial of Psilocybin in Depression
  (6/27/22)
In this trial, slated to commence next quarter, the biopharma will test the efficacy of its version of the psychedelic compound in this mental health indication, noted a ROTH Capital Partners report. More >

Approval Likely of New Gel for Skin Condition, Analyst Says
  (6/27/22)
The biotech developer of this gene therapy is preparing to launch it commercially in the U.S. and pursuing approval of it elsewhere in the world, noted an H.C. Wainwright & Co. report. More >

Co. Secures Option to Acquire Its 15th Uranium Asset
  (6/27/22)
The mining firm plans to drill at this Athabasca Basin property this year, noted a Fundamental Research report. More >

EU Biopharma Co. Makes $247M Bid for US Oncology Co.
Source: Streetwise Reports  (6/27/22)
Epizyme Inc. shares traded 55% higher today after the company reported that it agreed to be acquired by Ipsen S.A. of France for $1.45 per share along with a contingent value right of $1.00 per share. More >

Gold Mining Firm Is the 'Poster Child of Prospect Generators'
Source: The Critical Investor  (6/25/22)
The Critical Investor looks into the latest drill results of this junior miner at its Regnault target, which could be very close to 1 Moz gold now. More >